Study to Assess the Efficacy and Safety of Allogeneic Osteoblastic Cells (ALLOB®) Single Implantation in Tibial Fracture

NCT04432389 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Tibial Fracture

Interventions

BIOLOGICAL: ALLOB
OTHER: placebo

Sponsor

Bone Therapeutics S.A

Collaborators

[object Object]